104 related articles for article (PubMed ID: 10963057)
1. In vitro metabolism of human and salmon calcitonins in rat liver and kidney evaluated by liquid chromatography-tandem mass spectrometry.
Kobayashi N; Yamamura N; Kamagata M; Kurihara A; Ikeda T
Xenobiotica; 2000 Jul; 30(7):655-64. PubMed ID: 10963057
[TBL] [Abstract][Full Text] [Related]
2. Degradation of salmon calcitonin in rat kidney and liver homogenates.
Liao S; Zhang ZQ; Ruan JX; Qi JK; Liu KL
Pharmazie; 2008 Oct; 63(10):743-7. PubMed ID: 18972837
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of human calcitonin in excised bovine nasal mucosa: elucidation of the metabolic pathway by liquid secondary ionization mass spectrometry (LSIMS) and matrix assisted laser desorption ionization mass spectrometry (MALDI).
Lang SR; Staudenmann W; James P; Manz HJ; Kessler R; Galli B; Moser HP; Rummelt A; Merkle HP
Pharm Res; 1996 Nov; 13(11):1679-85. PubMed ID: 8956334
[TBL] [Abstract][Full Text] [Related]
4. Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues.
Taylor JW; Jin QK; Sbacchi M; Wang L; Belfiore P; Garnier M; Kazantzis A; Kapurniotu A; Zaratin PF; Scheideler MA
J Med Chem; 2002 Feb; 45(5):1108-21. PubMed ID: 11855991
[TBL] [Abstract][Full Text] [Related]
5. Renal metabolism of calcitonin.
Simmons RE; Hjelle JT; Mahoney C; Deftos LJ; Lisker W; Kato P; Rabkin R
Am J Physiol; 1988 Apr; 254(4 Pt 2):F593-600. PubMed ID: 2833122
[TBL] [Abstract][Full Text] [Related]
6. In vitro metabolic stability of exendin-4: pharmacokinetics and identification of cleavage products.
Liao S; Liang Y; Zhang Z; Li J; Wang J; Wang X; Dou G; Zhang Z; Liu K
PLoS One; 2015; 10(2):e0116805. PubMed ID: 25723538
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M
Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
[TBL] [Abstract][Full Text] [Related]
8. Folding analysis of hormonal polypeptide calcitonins and the oxidized calcitonins using electrospray ionization mass spectrometry combined with H/D exchange.
Nabuchi Y; Asoh Y; Takayama M
J Am Soc Mass Spectrom; 2004 Nov; 15(11):1556-64. PubMed ID: 15519222
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of porcine, human and salmon calcitonin in the rat.
de Luise M; Martin TJ; Greenberg PB; Michelangeli V
J Endocrinol; 1972 Jun; 53(3):475-82. PubMed ID: 5039226
[No Abstract] [Full Text] [Related]
10. Isolation, characterization, and stability of positional isomers of mono-PEGylated salmon calcitonins.
Lee KC; Moon SC; Park MO; Lee JT; Na DH; Yoo SD; Lee HS; DeLuca PP
Pharm Res; 1999 Jun; 16(6):813-8. PubMed ID: 10397599
[TBL] [Abstract][Full Text] [Related]
11. Stability of PEGylated salmon calcitonin in nasal mucosa.
Na DH; Youn YS; Park EJ; Lee JM; Cho OR; Lee KR; Lee SD; Yoo SD; DeLuca PP; Lee KC
J Pharm Sci; 2004 Feb; 93(2):256-61. PubMed ID: 14705183
[TBL] [Abstract][Full Text] [Related]
12. Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man.
Huwyler R; Born W; Ohnhaus EE; Fischer JA
Am J Physiol; 1979 Jan; 236(1):E15-9. PubMed ID: 571211
[TBL] [Abstract][Full Text] [Related]
13. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
[TBL] [Abstract][Full Text] [Related]
14. High-yield production of biologically active mono-PEGylated salmon calcitonin by site-specific PEGylation.
Youn YS; Na DH; Lee KC
J Control Release; 2007 Feb; 117(3):371-9. PubMed ID: 17207880
[TBL] [Abstract][Full Text] [Related]
15. Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of salmon calcitonin.
Cheng W; Lim LY
Mol Pharm; 2008; 5(4):610-21. PubMed ID: 18481870
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of polyethylene-glycol-modified salmon calcitonins.
Lee KC; Tak KK; Park MO; Lee JT; Woo BH; Yoo SD; Lee HS; DeLuca PP
Pharm Dev Technol; 1999 May; 4(2):269-75. PubMed ID: 10231888
[TBL] [Abstract][Full Text] [Related]
17. Distribution study of cisplatin in rat kidney and liver cancer tissues by using liquid chromatography electrospray ionization tandem mass spectrometry.
Bandu R; Ahn HS; Lee JW; Kim YW; Choi SH; Kim HJ; Kim KP
J Mass Spectrom; 2015 Jun; 50(6):844-53. PubMed ID: 26169139
[TBL] [Abstract][Full Text] [Related]
18. Further evidence for calcitonin gene duplication: the identification of two different calcitonins in a fish, a reptile and two mammals.
Perez Cano R; Girgis SI; MacIntyre I
Acta Endocrinol (Copenh); 1982 Jun; 100(2):256-61. PubMed ID: 7113594
[TBL] [Abstract][Full Text] [Related]
19. A chimeric analog of human and salmon calcitonin eliminates antigenicity and reduces gastrointestinal disturbances.
Kozono T; Hirata M; Endo K; Satoh K; Takanashi H; Miyauchi T; Fukushima N; Kumagai E; Abe S; Matsuda E
Endocrinology; 1992 Dec; 131(6):2885-90. PubMed ID: 1280207
[TBL] [Abstract][Full Text] [Related]
20. Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58).
Tréhin R; Nielsen HM; Jahnke HG; Krauss U; Beck-Sickinger AG; Merkle HP
Biochem J; 2004 Sep; 382(Pt 3):945-56. PubMed ID: 15193145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
